Cellenkos

About:

Cellenkos is a clinical stage biotech company.

Website: https://www.cellenkosinc.com/

Top Investors: BVCF

Description:

Cellenkos is a clinical-stage biotech company focused on the development and commercialization of transformative novel allogeneic Treg cell therapies to treat autoimmune and inflammatory disorders.

Total Funding Amount:

$15M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2016-01-01

Founders:

Simrit Parmar

Number of Employees:

11-50

Last Funding Date:

2021-11-04

IPO Status:

Private

Industries: